We may have found a solution: the Relaxis stimulation pad. We
place the FDA-approved sleep aid (myrelaxis.com) beneath the
calves of our restless-leg cataract patients, where it generates
adjustable therapeutic vibrations that counteract the discomfort of
RLS through distraction. The results from our recent Relaxis trial
were impressive. Before admission, we identified 15 consecutive
patients with RLS symptoms and administered Relaxis treatment
beginning in pre-op. Of those, only 1 required intraoperative conver-
sion to general anesthesia due to insufficient control of the leg move-
ments.
Anthony Mannarino, MD
Pamela Ledger, MSN, RN, CNE
The Ambulatory Surgery Center at St. Mary
Langhorne, Pa.
pledger@ascatsm.com
S E P T E M B E R 2 0 1 6 • O U T PA T I E N TS U R G E R Y. N E T • 2 1
